-
Management of Co-Occurring Conditions of Down Syndrome Becoming More Personalized
Clinical Research News | Medical conditions vary widely in presentation, progression, and treatment response, with Down syndrome standing out as one of the most variable of all. The genetic occurrence, caused by an extra copy of chromosome 21, is widely considered one of the most heterogenous conditions, with highly variable clinical presentation from person to person.
Aug 13, 2026
-
Blood Biomarker Panel May Enable Earlier ALS Prevention Trials
Clinical Research News | Investigators at the University of Miami Miller School of Medicine reported that a 19-protein blood biomarker panel, which includes neurofilament light chain (NfL), accurately predicted the transition from presymptomatic disease to clinical amyotrophic lateral sclerosis (ALS), known as phenoconversion, across timeframes ranging from six months to five years.
Aug 12, 2026
-
Primary Care Research Alliance ‘Flips the Script’ on Site Feasibility
Clinical Research News | In the U.K., adversity has brought together 180 clinical trial sites—mostly GP (general practitioner) practices but also community health trusts, hospices, and home care providers—to realize that they have more to gain as collaborators than competitors. The mindset shift prompted the formation of the Primary Care Research Alliance (PCRA), which in the space of 18 months has grown from a core group of 12 practices with 250,000 patients to a network representing 8.5 million and counting.
Aug 11, 2026
-
The Scope of Things: Chinese Drug Developers Look Toward Global Market
Clinical Research News | In the most recent episode of The Scope of Things podcast, Daphne Smyth, head of global regulatory programs at Veristat, joins the conversation to relay her three days at BioChina 2026 in Suzhou and what the North American and European markets can expect from Chinese drug development.
Aug 6, 2026
-
Vaccine ‘Intercepts’ Pancreatic Cancer in High-Risk Populations
Clinical Research News | Fresenius expands its access to innovation networks through its own corporate venture capital fund; Draig accelerates pipeline of highly specific AMPA and GABAA receptor modulators; and more.
Aug 4, 2026
-
Fresh Insights on What Helps Patient Recovery in the ICU
Clinical Research News | The findings of more than 150 randomized controlled trials provide ample evidence that early mobilization of patients with acute respiratory failure (ARF) in the intensive care unit (ICU) is both safe and beneficial. Surprisingly, also giving them extra protein—a strategy used successfully with frail and elderly patients—doesn’t appear to have any additive benefit.
Jul 30, 2026
-
Follow the Money: Metastatic Prostate Cancer, Once-Weekly GLP-1 Patch, Molecule Arts Platform
Clinical Research News | Fresenius expands its access to innovation networks through its own corporate venture capital fund; Draig accelerates pipeline of highly specific AMPA and GABAA receptor modulators; and more.
Jul 29, 2026
-
Flatiron Health UK, NHS Greater Glasgow and Clyde New Partnership, Acrosian’s Next-Gen Biometrics CRO, Spatial Biology in Clinical Research
Clinical Research News | Parhelia Biosciences and Sirona Dx announce a strategic partnership; The University of Cincinnati and UC Health launched the Center for Alzheimer's and Neurodegenerative Diseases Research; and more.
Jul 28, 2026
-
Flatiron Health UK, NHS Greater Glasgow and Clyde New Partnership, Acrosian’s Next-Gen Biometrics CRO, Spatial Biology in Clinical Research
Clinical Research News | Parhelia Biosciences and Sirona Dx announce a strategic partnership; The University of Cincinnati and UC Health launched the Center for Alzheimer's and Neurodegenerative Diseases Research; and more.
Jul 28, 2026
